Pieter MUNTENDAM - USA
Pieter Muntendam is a trained physician who has devoted his career to medical innovation by developing novel pharmaceuticals, medical devices, and services for payers and employers to reduce the burden of common conditions such as cardiac disease, diabetes and asthma. Dr. Muntendam is the inventor of a novel galectin-3 assay that was approved for clinical use by the FDA in 2010 for use in patients with heart failure. He has raised over $250M in public and private funding as CEO of early-stage companies.